TransMedics Group, Inc. Cash Equivalents, at Carrying Value
TransMedics Group, Inc. (TMDX) had Cash Equivalents, at Carrying Value of $4.66 million as of 2019-03-30, per its 10-Q filed 2019-06-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashEquivalentsAtCarryingValue · last filed 2020-03-17
- 2019-03-30: Cash Equivalents, at Carrying Value $4.66M.
- 2018-12-29: Cash Equivalents, at Carrying Value $13.59M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2019-03-30 | $4.66M 10-Q · filed 2019-06-12 |
| 2018-12-29 | $13.59M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |